Oestrogen-receptor status and sites of metastasis in breast cancer.

Abstract:

:The oestrogen receptor (RE) status of the primary tumour has been assessed in 466 of a consecutive series of 550 patients with primary operable breast cancer. All patients were followed up (without treatment) until the development of recurrence or metastases. Distant metastases have so far occurred in 124 patients and 82 have had symptomatic local or regional recurrence. A significant correlation exists between the RE status of the primary tumour and subsequent patterns of metastasis. Symptomatic metastases to regional lymph nodes are more common with RE- cancers. There is no significant difference in either time of onset or total incidence of distant metastases between patients with RE+ and RE- tumours. Distribution of distant metastases is influenced by RE status: RE+ tumours tend to recur in bone, RE- tumours show affinity for viscera.

journal_name

Br J Cancer

authors

Campbell FC,Blamey RW,Elston CW,Nicholson RI,Griffiths K,Haybittle JL

doi

10.1038/bjc.1981.205

subject

Has Abstract

pub_date

1981-09-01 00:00:00

pages

456-9

issue

3

eissn

0007-0920

issn

1532-1827

journal_volume

44

pub_type

杂志文章
  • Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.

    abstract:BACKGROUND:The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and histamine H4 receptor (H4R) ligands in a triple-negative breast cancer (TNBC) model developed in immunocompetent hosts. By using publicly available genomic data, ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-019-0636-x

    authors: Nicoud MB,Sterle HA,Massari NA,Táquez Delgado MA,Formoso K,Herrero Ducloux MV,Martinel Lamas D,Cremaschi GA,Medina VA

    更新日期:2020-02-01 00:00:00

  • Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity?

    abstract:BACKGROUND:Around 60% of women ≥ 80 years old, in the UK do not have surgery for their breast cancer (vs<10% of younger age groups). The extent to which this difference can be accounted for by co-morbidity has not been established. METHODS:A Cancer Registry/Hospital Episode Statistics-linked data set identified women ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.192

    authors: Lavelle K,Downing A,Thomas J,Lawrence G,Forman D,Oliver SE

    更新日期:2012-09-25 00:00:00

  • Does deprivation affect breast cancer management?

    abstract::We evaluated whether social deprivation affected decision-making for breast cancer surgery. Of 3419 patients, 53.6% had mastectomy and this was predicted by deprivation, age, tumour size and hospital, all of which retained significance on multivariate analysis, except deprivation. Pathological characteristics and surg...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602390

    authors: Henley NC,Hole DJ,Kesson E,Burns HJ,George WD,Cooke TG

    更新日期:2005-02-28 00:00:00

  • A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer.

    abstract::Oral capecitabine is a highly active, well-tolerated and convenient treatment for breast and colorectal cancer. This trial assessed the efficacy and safety of single-agent capecitabine in patients with previously treated ovarian cancer. A total of 29 patients with platinum-pretreated relapsed ovarian cancer were enrol...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/sj.bjc.6601381

    authors: Vasey PA,McMahon L,Paul J,Reed N,Kaye SB

    更新日期:2003-11-17 00:00:00

  • Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer.

    abstract::Palliative chemotherapy for inoperable/metastatic oesophageal cancer has limited activity. This study assesses the feasibility and activity of gemcitabine and cisplatin in this group of patients. In total, 42 patients with locally advanced/metastatic squamous or adenocarcinoma of the oesophagus were treated with gemci...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602842

    authors: Millar J,Scullin P,Morrison A,McClory B,Wall L,Cameron D,Philips H,Price A,Dunlop D,Eatock M

    更新日期:2005-11-14 00:00:00

  • A prospective study of urinary oestrogen excretion and breast cancer risk.

    abstract::To test the hypothesis that high levels of endogenous oestrogens increase the risk for developing breast cancer, concentrations of oestrone, oestradiol and oestriol were measured in 24 h urine samples from 1000 women participants in a prospective study of breast cancer on the island of Guernsey. Sixty-nine subjects we...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.304

    authors: Key TJ,Wang DY,Brown JB,Hermon C,Allen DS,Moore JW,Bulbrook RD,Fentiman IS,Pike MC

    更新日期:1996-06-01 00:00:00

  • Development and characterization of a tamoxifen-resistant breast carcinoma xenograft.

    abstract::A human tamoxifen-resistant mammary carcinoma, MaCa 3366/TAM, originating from a sensitive parental xenograft 3366 was successfully established by treatment of tumour-bearing nude mice with 1-50 mg kg(-1) tamoxifen for 3 years during routine passaging. Both tumours did not differ significantly in OR- and PR-positivity...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2000.1156

    authors: Naundorf H,Becker M,Lykkesfeldt AE,Elbe B,Neumann C,Büttner B,Fichtner I

    更新日期:2000-06-01 00:00:00

  • Do the British public recognise differences in survival between three common cancers?

    abstract:BACKGROUND:The recognition that cancer is not a single entity, rather that different cancers have different causes and trajectories, has been a key development in the scientific understanding of cancer. However, little is known about the British public's awareness of differences between cancers. This study examined dif...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.185

    authors: Whitaker KL,Simon AE,Beeken RJ,Wardle J

    更新日期:2012-06-05 00:00:00

  • Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

    abstract:BACKGROUND:Colorectal cancer (CRC) is the third most common cancer worldwide. Accurately identifying stage II CRC patients at risk for recurrence is an unmet clinical need. KCNQ1 was previously identified as a tumour suppressor gene and loss of expression was associated with poor survival in patients with CRC liver met...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2016.376

    authors: den Uil SH,Coupé VM,Linnekamp JF,van den Broek E,Goos JA,Delis-van Diemen PM,Belt EJ,van Grieken NC,Scott PM,Vermeulen L,Medema JP,Bril H,Stockmann HB,Cormier RT,Meijer GA,Fijneman RJ

    更新日期:2016-12-06 00:00:00

  • Association of physical activity with cancer incidence, mortality, and survival: a population-based study of men.

    abstract::Within a population-based cohort study, 40,708 men aged 45-79 years followed from 1998 to 2004. After adjusting for potential confounders, we observed a strong inverse linear association between total daily physical activity (PA) and death from cancer (n=1153). For each increment of 4 metabolic equivalent (MET)-h day(...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604354

    authors: Orsini N,Mantzoros CS,Wolk A

    更新日期:2008-06-03 00:00:00

  • Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies.

    abstract:BACKGROUND:Few studies have investigated the relationship between physician and patient-assessed performance status (PS) in blood cancers. METHODS:Retrospective analysis among 1418 patients with haematologic malignancies seen at Dana-Farber Cancer Institute between 2007 and 2014. We analysed physician-patient agreemen...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2016.260

    authors: Liu MA,Hshieh T,Condron N,Wadleigh M,Abel GA,Driver JA

    更新日期:2016-09-27 00:00:00

  • Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer.

    abstract:BACKGROUND:Tissue micro-arrays (TMAs) are increasingly used to generate data of the molecular phenotype of tumours in clinical epidemiology studies, such as studies of disease prognosis. However, TMA data are particularly prone to missingness. A variety of methods to deal with missing data are available. However, the v...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析

    doi:10.1038/sj.bjc.6606078

    authors: Ali AM,Dawson SJ,Blows FM,Provenzano E,Ellis IO,Baglietto L,Huntsman D,Caldas C,Pharoah PD

    更新日期:2011-02-15 00:00:00

  • Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.

    abstract::Tumour angiogenesis is essential for progression of solid tumours and constitutes an interesting target for therapy. However, impaired tumour blood supply may also be an important obstacle for treatment by radiotherapy and chemotherapy. Estramustine has been shown to increase tumour blood flow and potentiate the effec...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6690333

    authors: Johansson M,Bergenheim AT,Widmark A,Henriksson R

    更新日期:1999-04-01 00:00:00

  • Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer.

    abstract::We examined the levels of expression of the multidrug resistance-associated protein (MRP) gene quantified by Northern blot analysis in comparison with those of the MDR1 gene determined by reverse transcription-polymerase chain reaction (RT-PCR) in 104 non-small-cell lung cancer (NSCLC) specimens [59 adenocarcinoma (Ad...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1995.372

    authors: Ota E,Abe Y,Oshika Y,Ozeki Y,Iwasaki M,Inoue H,Yamazaki H,Ueyama Y,Takagi K,Ogata T

    更新日期:1995-09-01 00:00:00

  • Association between serum 25(OH)D and death from prostate cancer.

    abstract::Based on observations that for certain cancers, mortality varies according to sun exposure, vitamin D has been proposed to influence on disease progression. This study aims to investigate whether serum levels of 25(OH)D are associated with prognosis in patients with prostate cancer. In total, 160 patients with a serum...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604865

    authors: Tretli S,Hernes E,Berg JP,Hestvik UE,Robsahm TE

    更新日期:2009-02-10 00:00:00

  • Association of rib anomalies and childhood cancers.

    abstract:BACKGROUND:Congenital anomalies have been found more often in children with cancer than in those without. Rib abnormalities (RAs) have been associated with childhood cancer; however, studies have differed in the type of RAs and cancers implicated. METHODS:Rib abnormalities were assessed predominantly by X-ray in a hos...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.366

    authors: Zierhut H,Murati M,Holm T,Hoggard E,Spector LG

    更新日期:2011-10-25 00:00:00

  • Circulating immune complexes and autoantibodies in lung cancer.

    abstract::The sera of 80 newly diagnosed lung-cancer patients have been examined for immune complexes and autoantibodies. Control subjects consisted of 20 bronchitic patients and 150 normal blood donors. Immune-complex measurements used 4 established and sensitive techniques (Raji cell assay, fluid and solid-phase C1q assays an...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1981.45

    authors: Guy K,Di Mario U,Irvine WJ,Hunter AM,Hadley A,Horne NW

    更新日期:1981-03-01 00:00:00

  • ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial.

    abstract:BACKGROUND:Cisplatin-radiotherapy is a preferred standard for locally advanced, head and neck squamous cell carcinoma (HNSCC). However, the cisplatin-attributable survival benefit is small and toxicity substantial. A biomarker of cisplatin resistance could guide treatment selection and spare morbidity. The ERCC1-XPF nu...

    journal_title:British journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/bjc.2013.576

    authors: Bauman JE,Austin MC,Schmidt R,Kurland BF,Vaezi A,Hayes DN,Mendez E,Parvathaneni U,Chai X,Sampath S,Martins RG

    更新日期:2013-10-15 00:00:00

  • Comparison of tumour susceptibility among various organs of foetal, young and adult ICR/Jcl mice.

    abstract::Urethane was found to be uniformly distributed in all the major organs of foetal, young and adult ICR/Jcl mice and then to disappear rapidly as measured by the incorporation of urethane-carbonyl-14C, thus permitting the accurate comparison of tumour susceptibility of cells in various organs of mice at different ages. ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1976.83

    authors: Nomura T

    更新日期:1976-05-01 00:00:00

  • Metastasis of a transplantable mammary tumour in rats treated with cyclophosphamide and/or irradiation.

    abstract::We report observations on the spread by metastasis and infiltration of a transplantable tumour in rats treated by 60Co gamma-irradiation of the primary, irradiation plus parenteral cyclophosphamide, or parenteral cyclophosphamide alone. The proportion of animals with overt disseminated disease and the extent of spread...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1977.181

    authors: Moore JV,Dixon B

    更新日期:1977-08-01 00:00:00

  • Morphologic analysis of digestive cancers from the registry of Vaud, Switzerland.

    abstract::Detailed data and statistics per each morphological site of various digestive neoplasms were obtained for the period 1976-87 from the Vaud Cancer Registry datafile, a population-based cancer registration scheme covering about 530,000 inhabitants from the French-speaking part of Switzerland. Tabulations presented inclu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1991.132

    authors: Levi F,La Vecchia C,Franceschi S,Te VC

    更新日期:1991-04-01 00:00:00

  • Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases.

    abstract:BACKGROUND:Systemic inflammation measured by the neutrophil-to-lymphocyte ratio (NLR), leucocyte-to-lymphocyte ratio (LLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) and CRP/albumin ratio (CRP/Alb) was shown to impact the survival prognosis in patients with extracranial solid cancer. METHO...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-020-01254-0

    authors: Starzer AM,Steindl A,Mair MJ,Deischinger C,Simonovska A,Widhalm G,Gatterbauer B,Dieckmann K,Heller G,Preusser M,Berghoff AS

    更新日期:2021-01-21 00:00:00

  • Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.

    abstract::Novel synthetic antagonists of retinoic acid receptors (RARs) have been developed. To avoid interference by serum retinoids when testing these compounds, we established serum-free grown sub-lines (>3 years) of the prostate carcinoma lines LNCaP, PC3 and DU145. A high affinity pan-RAR antagonist (AGN194310, K(d) for bi...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2001.1939

    authors: Hammond LA,Van Krinks CH,Durham J,Tomkins SE,Burnett RD,Jones EL,Chandraratna RA,Brown G

    更新日期:2001-08-03 00:00:00

  • Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.

    abstract:BACKGROUND:Activated anaplastic lymphoma kinase (ALK) gene fusions are recurrent events in a small fraction of colorectal cancers (CRCs), although these events have not yet been exploited as in other malignancies. METHODS:We detected ALK protein expression by immunohistochemistry and gene rearrangements by fluorescenc...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2015.401

    authors: Amatu A,Somaschini A,Cerea G,Bosotti R,Valtorta E,Buonandi P,Marrapese G,Veronese S,Luo D,Hornby Z,Multani P,Murphy D,Shoemaker R,Lauricella C,Giannetta L,Maiolani M,Vanzulli A,Ardini E,Galvani A,Isacchi A,Sartore

    更新日期:2015-12-22 00:00:00

  • A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.

    abstract:BACKGROUND:Our previous laboratory and clinical data suggested that one mechanism underlying the development of platinum resistance in ovarian cancer is the acquisition of DNA methylation. We therefore tested the hypothesis that the DNA hypomethylating agent 5-aza-2'-deoxycytodine (decitabine) can reverse resistance to...

    journal_title:British journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/bjc.2014.116

    authors: Glasspool RM,Brown R,Gore ME,Rustin GJ,McNeish IA,Wilson RH,Pledge S,Paul J,Mackean M,Hall GD,Gabra H,Halford SE,Walker J,Appleton K,Ullah R,Kaye S,Scottish Gynaecological Trials Group.

    更新日期:2014-04-15 00:00:00

  • The impact of lymph node density on survival of cervical cancer patients.

    abstract:BACKGROUND:To evaluate the prognostic value of lymph node density (LND) in patients with lymph node-positive cervical cancer. METHODS:A total of 88 consecutive patients were included in our study. Patients were treated with cisplatin-based concomitant chemoradiotherapy after surgical staging was performed at the Medic...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605801

    authors: Polterauer S,Hefler L,Seebacher V,Rahhal J,Tempfer C,Horvat R,Reinthaller A,Grimm C

    更新日期:2010-08-24 00:00:00

  • ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases.

    abstract::The activity of ZD 1839 on brain metastases (BM) from Non-Small-Cell Lung Cancer (NSCLC) is unknown. We report four cases of BM responding to ZD 1839 theraphy. ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6601116

    authors: Cappuzzo F,Calandri C,Bartolini S,Crinò L

    更新日期:2003-07-21 00:00:00

  • Tumour-marker levels and prognosis in malignant teratoma of the testis.

    abstract::The effect of 6 putative prognostic factors on survival was studied in patients with Stages III and IV malignant teratoma of the testis. Differences between survival curves were tested for statistical significance. A diameter greater than 5 cm in the largest tumour mass, and greater than 8 pulmonary metastases were ad...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.332

    authors: Germa-Lluch JR,Begent RH,Bagshawe KD

    更新日期:1980-12-01 00:00:00

  • Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients.

    abstract::Cell line studies demonstrate that the PI3K/Akt pathway is upregulated in hormone-refractory prostate cancer (HRPC) and can result in phosphorylation of the androgen receptor (AR). The current study therefore aims to establish if this has relevance to the development of clinical HRPC. Immunohistochemistry was employed...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604152

    authors: McCall P,Gemmell LK,Mukherjee R,Bartlett JM,Edwards J

    更新日期:2008-03-25 00:00:00

  • Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.

    abstract::Serum protein induced by vitamin K absence or antagonist II (PIVKAII), hepatoma-specific band of serum gamma-glutamyl transferase (GGTII), and alpha-fetoprotein (AFP) levels were determined in 120 patients with hepatocellular carcinoma (HCC) and 90 patients with cirrhosis. The mean serum concentration of PIVKAII in HC...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6601018

    authors: Cui R,He J,Zhang F,Wang B,Ding H,Shen H,Li Y,Chen X

    更新日期:2003-06-16 00:00:00